Franklin Resources Inc Arbutus Biopharma Corp Transaction History

Franklin Resources Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$1.91 - $2.85 $219 - $327	-115 Reduced 0.36%	31,436 $73,000
Q3 2022 Nov 14, 2022	BUY	$1.88 - $2.88 $157 - $241	84 Added 0.27%	31,551 $60,000
Q2 2022 Aug 11, 2022	SELL	$1.98 - $3.17 $28,577 - $45,752	-14,433 Reduced 31.44%	31,467 $85,000
Q1 2022 May 13, 2022	BUY	$2.42 - $3.98 $111,078 - $182,682	45,900 New	45,900 $137,000

155

99.5M

2.31M

525K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $478M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.